Clinical features of Pseudomonas cepacia pneumonia in an epidemic among immunocompromised patients

Area of Science:

• Infectious Diseases
• Pulmonology
• Critical Care Medicine

Background:

• Nosocomial outbreaks of Pseudomonas cepacia (P. cepacia) pose a significant threat to immunocompromised patients.
• Contaminated respiratory equipment, particularly nebulizers, can serve as a reservoir for P. cepacia transmission in hospital settings.

Purpose of the Study:

• To investigate an outbreak of P. cepacia colonization and pneumonia among patients with hematologic malignancies or solid tumors.
• To characterize the clinical features, risk factors, and antimicrobial resistance patterns associated with P. cepacia in this patient cohort.

Main Methods:

• Retrospective review of medical records for 37 patients colonized with P. cepacia between January 1990 and August 1991.
• Surveillance cultures of environmental surfaces and respiratory equipment to identify the source of contamination.
• Analysis of clinical data, chest X-ray findings, and antimicrobial susceptibility testing of P. cepacia isolates.

Main Results:

• Nebulizing devices used for aerosolized antibiotic prophylaxis were identified as the source of P. cepacia contamination.
• Sixteen of 37 patients developed P. cepacia pneumonia, characterized by lobular infiltrates, with some cases showing cavity formation and pleural effusion.
• The majority of P. cepacia strains exhibited multidrug resistance, with ceftazidime and minocycline showing the highest susceptibility rates.

Conclusions:

• Contaminated nebulizers represent a critical risk factor for nosocomial P. cepacia pneumonia in immunocompromised patients.
• The clinical presentation of P. cepacia pneumonia can include significant radiographic abnormalities.
• Effective treatment strategies must consider the high prevalence of antimicrobial resistance among P. cepacia isolates.